#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nephropathy Encephalitis autoimmune Anti-HLA antibody test positive Li-Fraumeni syndrome Red blood cell abnormality Colon cancer Glioma Acute graft versus host disease in liver Graft versus host disease Thalassaemia beta Vulval cancer recurrent Dent's disease Wolfram syndrome Lymphangioma Peritoneal mesothelioma malignant More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Basic Information Pulmonary fibrosis – Trials in Disease Alternating hemiplegia of childhood – Treatment Crigler-Najjar syndrome – Treatment Sarcoma Atypical haemolytic uraemic syndrome – Life with Disease Mucous membrane pemphigoid – Basic Information Primary immunodeficiency syndrome Lysosomal storage disorder – Diagnostics Burkitt’s lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Foscarnet Sodium Hexahydrate Estradiol [18F]-Altanserin Bimekizumab Hydrocortisone Ph. Eur. Teriparatide Tin816 Fremanezumab Ioflupane (123I) 13N-AMMONIA MB-HUCART19.1 Levofloxacin Hemihydrate Aclidinium Bromide Cendakimab Bms-986449-03 Oditrasertib Ep0042 GSKVX000000048111 Paracetamol Ph. Eur. Mepivacaine Hydrochloride More therapies…

    Learn about Your Condition

    Femoral hernia Chronic kidney disease Glomerulonephritis Breast conserving surgery Cirrhosis alcoholic Varicella Chronic fatigue syndrome Somatic symptom disorder Ocular myasthenia Dupuytren's contracture Breast cancer stage III Myopia Asplenia Immunodeficiency congenital Oxygen therapy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effect of Semaglutide on Healing Foot Ulcers in Patients with Type 2 Diabetes

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Denmark
  • Study on Tacrolimus and Sirolimus for Kidney Transplant Patients at High Risk of Cytomegalovirus Infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Valganciclovir
    • Sirolimus
    Spain
  • Study on How Gut Bacteria Affect Energy Use in Cells for Healthy Adults and Patients with Inflammatory Bowel Disease Using Amphotericin B, Vancomycin, and Gentamicin Sulfate

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    Investigated Drugs:
    • Gentamicin Sulfate
    • Vancomycin
    • Amphotericin B
    France
  • Study on Pravastatin for Pregnant Patients with Preeclampsia or Intrauterine Growth Restriction

    Recruiting

    3 1 1
    Investigated Drugs:
    • Pravastatin Sodium
    Spain
  • Study on Reducing Sodium Chloride and Glucose in Fluids for Critically Ill Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Magnesium Chloride Hexahydrate
    • Sodium Gluconate
    • Glucose Monohydrate
    Belgium
  • Study on Psilocybin and Trazodone for Adults with Treatment-Resistant Depression

    Recruiting

    2 1 1
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    • TRAZODONE HYDROCHLORIDE
    France
Previous Page
1 … 182 183 184 185 186 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!